pecanfolder85
Active member
Would use dutasteride after, gives transplanted hairs best shot. Found GLPs and TRT bad combo for hair loss though.
-
This forum is for informational purposes only and does not provide medical advice. Read our Medical Disclaimer. | Privacy | Terms | About | Cookie Policy | Editorial Policy | This site may contain sponsored content and affiliate links.
Reta: TRT's New Best Friend?
- Thread starter Funky_Gal
- Start date
wobbly_whittler115
Well-known member
Congrats on dropping the weight. Best approach is donating the old pieces and moving forward. Try charity shops, shelters, or those bins in parking lots. Just hand them off. Feels good, plus it's symbolic of closing one chapter and starting fresh with new patterns and thinking. This is my take on it-if weight goes up later, deal with it then, but keep the closet uncluttered with excuses to regress.
B_W_Thompson
Active member
don't know about the trial cohorts starting at 4mg, but you're not really a beginner at this point 
wobbly_whittler115
Well-known member
The triple agonist mechanism - GLP-1, GIP, and glucagon simultaneously - is what drives the difference in visceral fat reduction relative to single or dual agonist options. The TRT interaction is real; both affect body composition through different but complementary pathways.
The most recent Phase 3 data, released across December of last year and March of this year, shows retatrutide expanding well past being labeled just a weight loss medication. Since it works on three separate hormone receptors at once, the glucagon-like pathway plus the two others tied to blood sugar regulation, it functions more like a broad metabolic reset tool.
Here's a rundown of the newest findings on retatrutide's benefits beyond weight, this whole drug class is clearly having a moment, showing strong results for people chasing weight loss and plenty beyond that too.
1. Results published in mid-March showed significant efficacy for blood sugar control:
A1C dropped by an average of roughly one and three quarters to two full percentage points across the 40-week trial.
Blood sugar reach: many participants landed at near-normal glucose levels, hinting this compound might outperform current dual-agonists for glycemic management.
2. One of the more unexpected findings from the December data centered on chronic pain:
Pain relief: participants saw a roughly 76 percent drop in standard osteoarthritis pain index scores.
Mechanical versus inflammatory: while some of that traces back to less stress on the joints from lower body weight, the medication also meaningfully reduced
Here's a rundown of the newest findings on retatrutide's benefits beyond weight, this whole drug class is clearly having a moment, showing strong results for people chasing weight loss and plenty beyond that too.
1. Results published in mid-March showed significant efficacy for blood sugar control:
A1C dropped by an average of roughly one and three quarters to two full percentage points across the 40-week trial.
Blood sugar reach: many participants landed at near-normal glucose levels, hinting this compound might outperform current dual-agonists for glycemic management.
2. One of the more unexpected findings from the December data centered on chronic pain:
Pain relief: participants saw a roughly 76 percent drop in standard osteoarthritis pain index scores.
Mechanical versus inflammatory: while some of that traces back to less stress on the joints from lower body weight, the medication also meaningfully reduced